KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Synopsys (SNPS) Research & Development (2016 - 2026)

Synopsys filings provide 18 years of Research & Development readings, the most recent being $715.0 million for Q1 2026.

  • Quarterly Research & Development rose 29.24% to $715.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $2.6 billion through Jan 2026, up 25.17% year-over-year, with the annual reading at $2.5 billion for FY2025, 19.06% up from the prior year.
  • Research & Development hit $715.0 million in Q1 2026 for Synopsys, down from $746.8 million in the prior quarter.
  • Across five years, Research & Development topped out at $746.8 million in Q4 2025 and bottomed at $371.1 million in Q4 2022.
  • Average Research & Development over 5 years is $514.3 million, with a median of $493.1 million recorded in 2024.
  • The largest annual shift saw Research & Development decreased 10.34% in 2022 before it soared 34.61% in 2025.
  • Synopsys' Research & Development stood at $371.1 million in 2022, then rose by 25.53% to $465.8 million in 2023, then increased by 19.11% to $554.8 million in 2024, then soared by 34.61% to $746.8 million in 2025, then fell by 4.27% to $715.0 million in 2026.
  • Per Business Quant, the three most recent readings for SNPS's Research & Development are $715.0 million (Q1 2026), $746.8 million (Q4 2025), and $625.3 million (Q3 2025).